Bristol-Meyers Squibb (BMS) and Celgene kicked off the 37th Annual JP Morgan Healthcare Conference by discussing their leading drugs, near-term launches, and early pipeline assets. Kicking things off ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback